KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Agenus (AGEN) Shares Outstanding (Diluted Average) (2018 - 2025)

Agenus (AGEN) has 11 years of Shares Outstanding (Diluted Average) data on record, last reported at $28.1 million in Q2 2025.

  • For Q2 2025, Shares Outstanding (Diluted Average) rose 33.5% year-over-year to $28.1 million; the TTM value through Jun 2025 reached $28.1 million, up 33.5%, while the annual FY2024 figure was $21.5 million, 20.0% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $28.1 million in Q2 2025 per AGEN's latest filing, up from $24.5 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $28.1 million in Q2 2025 and bottomed at $222906.0 in Q2 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $12.9 million, with a median of $16.7 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Diluted Average): grew 17.92% in 2022, then skyrocketed 6267.58% in 2023.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $228919.0 in 2021, then soared by 6053.71% to $14.1 million in 2022, then rose by 27.02% to $17.9 million in 2023, then increased by 20.0% to $21.5 million in 2024, then surged by 30.94% to $28.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Diluted Average) were $28.1 million in Q2 2025, $24.5 million in Q1 2025, and $21.5 million in Q4 2024.